atipamezole has been researched along with Hyperactivity, Motor in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahsan, MR; Lin, Y; Quartermain, D; Stone, EA | 1 |
Haapalinna, A; Koistinaho, J; Miettinen, R; Puurunen, K; Riekkinen, P; Sirviö, J; Sivenius, J | 1 |
Haapalinna, A; Hakkarainen, V; Lappalainen, R; Niittykoski, M; Puumala, T; Ruotsalainen, S; Sirviö, J | 1 |
3 other study(ies) available for atipamezole and Hyperactivity, Motor
Article | Year |
---|---|
Evidence of roles of central alpha1-adrenoceptors and epinephrine in orexin A-induced hyperactivity in mice.
Topics: Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Epinephrine; Hyperkinesis; Imidazoles; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Male; Neuropeptides; Orexin Receptors; Orexins; Prazosin; Rats; Receptors, Adrenergic; Receptors, G-Protein-Coupled; Receptors, Neuropeptide | 2005 |
Studies on the influence of enriched-environment housing combined with systemic administration of an alpha2-adrenergic antagonist on spatial learning and hyperactivity after global ischemia in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Behavior, Animal; Brain Ischemia; Cerebrovascular Disorders; Disease Models, Animal; Environment; Hippocampus; Hyperkinesis; Imidazoles; Male; Maze Learning; Memory; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Spatial Behavior | 1997 |
Systemic administration of atipamezole, an alpha 2-antagonist, can reduce scopolamine-induced hyperactivity in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Hyperkinesis; Imidazoles; Male; Maze Learning; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Scopolamine; Swimming | 1997 |